MicroRNA-29b regulation of abdominal aortic aneurysm development

Trends in Cardiovascular Medicine

Volumn 24, Issue 1, 2014, Pages 1-6

  Maegdefessel, Lars ^a   Azuma, Junya ^b   Tsao, Philip S ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b OSAKA UNIVERSITY   (Japan)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 29B;

ABDOMINAL AORTA ANEURYSM; EXTRACELLULAR MATRIX; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; RNA TRANSLATION;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; PHENOTYPE; PROGNOSIS;

EID: 84890803353     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.05.002     Document Type: Review

References (46)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233.
3. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324(5935):1710-1713.
4. Boon R.A., Seeger T., Heydt S., Fischer A., Hergenreider E., Horrevoets A.J., et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circulation Research 2011, 109(10):1115-1119.
5. Chen K.C., Wang Y.S., Hu C.Y., Chang W.C., Liao Y.C., Dai C.Y., et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB Journal 2011, 25(5):1718-1728.
6. Cushing L., Kuang P.P., Qian J., Shao F., Wu J., Little F., et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology 2011, 45(2):287-294.
7. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics 2006, 38(9):1060-1065.
8. Garbacki N., Di Valentin E., Huynh-Thu V.A., Geurts P., Irrthum A., Crahay C., et al. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One 2011, 6(1):e16509.
9. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arteriosclerosis Thrombosis and Vascular Biology 2006, 26(12):2605-2613.
10. Golledge J., Norman P.E. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 2011, 217(1):57-63.
11. Hawkins S.M., Creighton C.J., Han D.Y., Zariff A., Anderson M.L., Gunaratne P.H., et al. Functional microRNA involved in endometriosis. Molecular Endocrinology 2011, 25(5):821-832.
12. He Y., Huang C., Lin X., Li J. MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie 2013, 95(7):1355-1359.
13. Hubmacher D., Apte S.S. The biology of the extracellular matrix: novel insights. Current Opinion in Rheumatology 2013, 25(1):65-70.
14. Jones J.A., Stroud R.E., O'Quinn E.C., Black L.E., Barth J.L., Elefteriades J.A. Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circulation Cardiovascular Genetics 2011, 4(6):605-613.
15. Ketting R.F., Fischer S.E., Bernstein E., Sijen T., Hannon G.J., Plasterk R.H. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes and Development 2001, 15(20):2654-2659.
16. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317(5842):1220-1224.
17. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology 2005, 6(5):376-385.
18. Krutzfeldt J., Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metabolism 2006, 4(1):9-12.
19. Kwiecinski M., Noetel A., Elfimova N., Trebicka J., Schievenbusch S., Strack I., et al. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One 2011, 6(9):e24568.
20. Lederle F.A., Johnson G.R., Wilson S.E. Aneurysm and management abdominal aortic aneurysm in women. Journal of Vascular Surgery 2001, 34(1):122-126. Veterans Affairs Cooperative.
21. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal 2004, 23(20):4051-4060.
22. Li Z., Hassan M.Q., Jafferji M., Aqeilan R.I., Garzon R., Croce C.M., et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. Journal of Biological Chemistry 2009, 284(23):15676-15684.
23. Lu H., Rateri D.L., Bruemmer D., Cassis L.A., Daugherty A. Novel mechanisms of abdominal aortic aneurysms. Current Atherosclerosis Reports 2012, 14(5):402-412.
24. Luna C., Li G., Qiu J., Epstein D.L., Gonzalez P. Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. Investigative Ophthalmology and Visual Science 2011, 52(6):3567-3572.
25. Maegdefessel L., Azuma J., Toh R., Merk D.R., Deng A., Chin J.T., et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. Journal of Clinical Investigation 2012, 122(2):497-506.
26. Maurer B., Stanczyk J., Jungel A., Akhmetshina A., Trenkmann M., Brock M., et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis and Rheumatism 2010, 62(6):1733-1743.
27. Mendell J.T., Olson E.N. MicroRNAs in stress signaling and human disease. Cell 2012, 148(6):1172-1187.
28. Merk D.R., Chin J.T., Dake B.A., Maegdefessel L., Miller M.O., Kimura N., et al. miR-29b participates in early aneurysm development in Marfan syndrome. Circulation Research 2012, 110(2):312-324.
29. Milewicz D.M. MicroRNAs, fibrotic remodeling, and aortic aneurysms. Journal of Clinical Investigation 2012, 122(2):490-493.
30. Mishra P.K., Tyagi N., Kumar M., Tyagi S.C. MicroRNAs as a therapeutic target for cardiovascular diseases. Journal of Cellular and Molecular Medicine 2009, 13(4):778-789.
31. Ogawa T., Iizuka M., Sekiya Y., Yoshizato K., Ikeda K., Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochemical and Biophysical Research Communications 2010, 391(1):316-321.
32. Pande R.L., Beckman J.A. Abdominal aortic aneurysm: populations at risk and how to screen. Journal of Vascular and Interventional Radiology 2008, 19(6 Suppl.):S2-S8.
33. Qin W., Chung A.C., Huang X.R., Meng X.M., Hui D.S., Yu C.M., et al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. Journal of the American Society of Nephrology 2011, 22(8):1462-1474.
34. Rayner K.J., Suarez Y., Davalos A., Parathath S., Fitzgerald M.L., Tamehiro N., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328(5985):1570-1573.
35. Sekiya Y., Ogawa T., Yoshizato K., Ikeda K., Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochemical and Biophysical Research Communications 2011, 412(1):74-79.
36. Small E.M., Frost R.J., Olson E.N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010, 121(8):1022-1032.
37. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469(7330):336-342.
38. Steele R., Mott J.L., Ray R.B. MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes and Cancer 2010, 1(4):381-387.
39. Suarez Y., Fernandez-Hernando C. New insights into microRNA-29 regulation: a new key player in cardiovascular disease. Journal of Molecular and Cellular Cardiology 2012, 52(3):584-586.
40. Sullivan C.S., Grundhoff A.T., Tevethia S., Pipas J.M., Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005, 435(7042):682-686.
41. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113(6):e85-e151. American Heart Association Statistics and Stroke Statistics.
42. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America 2006, A103(48):18255-18260.
43. Wang B., Komers R., Carew R., Winbanks C.E., Xu B., Herman-Edelstein M., et al. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. Journal of the American Society of Nephrology 2012, 23(2):252-265.
44. Wang Y., Zhang X., Li H., Yu J., Ren X. The role of miRNA-29 family in cancer. European Journal of Cell Biology 2013, 92(3):123-128.
45. Wienholds E., Plasterk R.H. MicroRNA function in animal development. FEBS Letters 2005, 579(26):5911-5922.
46. Zhang P., Huang A., Ferruzzi J., Mecham R.P., Starcher B.C., Tellides G., et al. Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels-brief report. Arteriosclerosis Thrombosis and Vascular Biology 2012, 32(3):756-759.